Interestingly, the expression of GINS2 is significantly correlated with multiple immune infiltration levels in human cancer, especially in LGG, LUSC, and TGCT, which indicates that GINS2 may mediate cancer progression by affecting immune infiltration in malignant tumours. The gene discussed is GINS2; the disease is cancer.